These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18455739)

  • 41. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
    Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
    Crean RD; Davis SA; Von Huben SN; Lay CC; Katner SN; Taffe MA
    Neuroscience; 2006 Oct; 142(2):515-25. PubMed ID: 16876329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc.
    Okada M; Fukuyama K; Kawano Y; Shiroyama T; Ueda Y
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00457. PubMed ID: 30784207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
    Fantegrossi WE; Ciullo JR; Wakabayashi KT; De La Garza R; Traynor JR; Woods JH
    Neuroscience; 2008 Jan; 151(2):533-43. PubMed ID: 18082974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
    Johnson BN; Yamamoto BK
    J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
    Nair SG; Gudelsky GA
    Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine.
    Matuszewich L; Filon ME; Finn DA; Yamamoto BK
    Neuroscience; 2002; 110(1):41-8. PubMed ID: 11882371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
    Orio L; Llopis N; Torres E; Izco M; O'Shea E; Colado MI
    Neurotox Res; 2010 Aug; 18(2):187-99. PubMed ID: 19777321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
    Suemaru J; Akiyama K; Tanabe Y; Kuroda S
    Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.
    Green AR; O'Shea E; Saadat KS; Elliott JM; Colado MI
    Br J Pharmacol; 2005 Sep; 146(2):306-12. PubMed ID: 15997230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
    Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
    Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
    Russell BR; Laverty R
    Pharmacol Biochem Behav; 2001 Mar; 68(3):565-74. PubMed ID: 11325413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.
    Darvesh AS; Shankaran M; Gudelsky GA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):138-44. PubMed ID: 11907167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.